×
About 918 results

ALLMedicine™ Thiamine Deficiency Center

Research & Reviews  310 results

Prevalence of Thiamine Deficiency in Hospitalized Non-Alcoholic Veterans
https://clinicaltrials.gov/ct2/show/NCT05480943

Jan 27th, 2023 - Background: Thiamine deficiency (TD) causes a variety of thiamine deficiency disorders (TDDs) such as neuropsychiatric disturbances, polyneuropathy, ataxia, weakness and falling, and non-ischemic heart failure. Left untreated, TD can be associated...

Can depressed cancer patients with a borderline thiamine concentration develop deficien...
https://doi.org/10.1017/S1478951522001808
Palliative & Supportive Care; Uchida N, Ishida M et. al.

Jan 24th, 2023 - Despite increasing reports of thiamine deficiency (TD) among cancer patients, there remain some patients with borderline thiamine concentrations (BTC). However, it is unclear whether such patients subsequently develop TD. Here, we report cases of ...

Thiamine deficiency disorders in women and children.
https://doi.org/10.1080/20469047.2023.2167158
Paediatrics and International Child Health; Keating EM, Johnson CR et. al.

Jan 17th, 2023 - Thiamine (vitamin B1) is available in common foods such as the outer husk of rice and is necessary for normal cardiovascular, neurological and metabolic processes. Thiamine deficiency is common in many parts of Asia and Africa, affecting up to a t...

Recognizing Neonatal Refeeding Syndrome and Thiamine Supplementation: A Case Report.
https://doi.org/10.1002/jpen.2474
JPEN. Journal of ParEnteral and Enteral Nutrition; Bradley C, Hansen A et. al.

Jan 13th, 2023 - Refeeding syndrome (RS) is a condition characterized by electrolyte derangements, thiamine deficiency, and organ dysfunction following provision of nutrition to an individual who had been deprived of nutrients. Published guidelines outlining the r...

Effect of Thiamine on Serum Glucagon And Reactive Oxygen Species (ROS)
https://clinicaltrials.gov/ct2/show/NCT05663164

Dec 23rd, 2022 - Surgery may increase postoperative cortisol and blood glucose levels. Changes in normal metabolic patterns due to surgery stimulate gluconeogenesis, glycogenolysis, proteolysis, lipolysis, and cytogenesis. These result in hyperglycemia and ketosis...

see more →

Drugs  13 results see all →

Clinicaltrials.gov  25 results

Prevalence of Thiamine Deficiency in Hospitalized Non-Alcoholic Veterans
https://clinicaltrials.gov/ct2/show/NCT05480943

Jan 27th, 2023 - Background: Thiamine deficiency (TD) causes a variety of thiamine deficiency disorders (TDDs) such as neuropsychiatric disturbances, polyneuropathy, ataxia, weakness and falling, and non-ischemic heart failure. Left untreated, TD can be associated...

Effect of Thiamine on Serum Glucagon And Reactive Oxygen Species (ROS)
https://clinicaltrials.gov/ct2/show/NCT05663164

Dec 23rd, 2022 - Surgery may increase postoperative cortisol and blood glucose levels. Changes in normal metabolic patterns due to surgery stimulate gluconeogenesis, glycogenolysis, proteolysis, lipolysis, and cytogenesis. These result in hyperglycemia and ketosis...

The Thiamine Administration After Cardiac Surgery Trial
https://clinicaltrials.gov/ct2/show/NCT04641104

Nov 17th, 2022 - Thiamine (Vitamin B1) is essential for cell function and as a co-factor of the enzyme Pyruvate Dehydrogenase to initiate the Krebs cycle and thus the aerobic metabolism of glucose. Thiamine deficiency, can be caused by alcoholism or bariatric surg...

Further Development and Assessment of Tools to Measure Risk Factors for and Treatment of Thiamine Deficiency Disorders
https://clinicaltrials.gov/ct2/show/NCT05390086

Sep 1st, 2022 - The study's primary objective is to determine the usefulness of a TRD case definition and practical tool in identifying infants and young children that would benefit from thiamine treatment in different contexts in Lao PDR, specifically urban Vien...

The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies
https://clinicaltrials.gov/ct2/show/NCT05145049

Jul 22nd, 2022 - Lactate level is one of the easy-to-measure parameters that are frequently used in anesthesia and intensive care clinical practice, especially to evaluate the severity of disease and the response to treatment. In patients with high lactate levels,...

see more →

News  19 results

Targeted Treatment Arsenal for Myelofibrosis Set to Explode
https://www.onclive.com/view/targeted-treatment-arsenal-for-myelofibrosis-set-to-explode

Apr 22nd, 2022 - Myelofibrosis is a highly heterogeneous disease, with patients having varying symptoms and presentations. The only cure is allogeneic stem cell transplantation; however, this treatment is not appropriate for many patients. Consequently, treatment ...

Determining Treatment for MF And Upfront Therapy Options
https://www.onclive.com/view/determining-treatment-for-mf-and-upfront-therapy-options

Feb 14th, 2022 - Ruben Mesa, MD: Let’s pivot a bit toward the therapy of myelofibrosis [MF] and, at the current time, we have a few tools in the toolkit and many more in development that we’ll be speaking of. We have, obviously, stem cell transplantation which we’...

Vitamin supplementation in healthy patients: What does the evidence support?
https://www.mdedge.com/familymedicine/article/247601/mens-health/vitamin-supplementation-healthy-patients-what-does
MDedge Family Medicine; Joel Herness, MD, Jennifer Svarverud, DO et. al.

Oct 20th, 2021 - Since their discovery in the early 1900s as the treatment for life-threatening deficiency syndromes, vitamins have been touted as panaceas for numerous ailments. While observational data have suggested potential correlations between vitamin status.

The Role of Fedratinib in Myelofibrosis
https://www.onclive.com/view/the-role-of-fedratinib-in-myelofibrosis

Apr 2nd, 2021 - Transcript: Harry Erba, MD, PhD: What’s new this year in the management of myelofibrosis in the United States is the FDA approval of fedratinib with a very broad indication of treated, previously treated, or previously untreated patients with i...

FDA Approvals in NTRK Fusion+ Tumors, ROS1+ NSCLC, and Myelofibrosis, and More
https://www.onclive.com/view/fda-approvals-in-ntrk-fusion-tumors-ros1-nsclc-and-myelofibrosis-and-more

Apr 2nd, 2021 - Today- FDA approvals in NTRK fusion—positive tumors, ROS1-positive non—small cell lung cancer, and myelofibrosis, priority review designations in prostate cancer and mantle cell lymphoma, and a breakthrough therapy designation in chronic lympho...

see more →